Ovarian Cancer Doctor in Dubai

Ovarian cancer is notoriously difficult to catch early because its symptoms—bloating, pelvic discomfort, changes in appetite—overlap heavily with far more common and less serious conditions. Many patients in Dubai are diagnosed only after imaging done for another reason picks up a mass, which means the first real conversation about treatment often starts with more advanced disease than anyone expected, and with a lot of decisions to make quickly.

Chat on WhatsApp Call Now

Get Consultation

Fill out the form and our team will contact you shortly.

Ovarian Cancer Doctor in Dubai - Dr. Ajeet Tiwari

Dr. Ajeet Tiwari is an MCh surgical oncologist who reviews ovarian cancer cases for patients in Dubai, explains what the imaging and tumor marker results actually mean, and sets out a clear surgical and chemotherapy plan once staging is complete.

Book a Consultation

This page covers what that process involves, including the genetic testing and fertility questions that come up most often.

Diagnosis and Staging Before Any Treatment Decision

Diagnosis typically combines a pelvic ultrasound or CT scan with a blood test for the CA-125 tumor marker, though CA-125 alone is not diagnostic and is interpreted alongside imaging findings, not in isolation. Formal staging, based on the FIGO system, is usually only confirmed during surgery itself, since it depends on exactly how far the cancer has spread within the pelvis and abdomen, which imaging alone cannot always show with certainty.

Why Ovarian Cancer Is Often Found at a Later Stage

The ovaries sit deep in the pelvis, and early tumors rarely cause symptoms specific enough to prompt urgent investigation. This is simply a feature of the disease, not a sign that anything was missed, and it is exactly why a thorough surgical and staging plan matters more here than in cancers that are typically caught earlier.

Ovarian Cancer Doctor in Dubai: BRCA and Genetic Testing

BRCA1 and BRCA2 gene testing is now a standard part of ovarian cancer workup, since a meaningful proportion of cases are linked to inherited mutations in these genes. A positive result affects treatment choices, including eligibility for certain targeted maintenance therapies after chemotherapy, and also has implications for family members who may wish to be tested.

Test	What It Tells the Treating Team
CA-125 blood test	A tumor marker used alongside imaging to support diagnosis and monitor treatment response over time
BRCA1 / BRCA2 genetic testing	Whether the cancer is linked to an inherited mutation, which can affect treatment choices and family screening
FIGO surgical staging	Confirms exactly how far the cancer has spread, established during the operation itself
Histopathology of removed tissue	Confirms the exact cancer subtype, which shapes chemotherapy drug selection

Debulking Surgery Explained

The main surgical goal in ovarian cancer, known as debulking or cytoreductive surgery, is to remove as much visible tumor as possible, since the amount of cancer left behind after surgery is one of the strongest predictors of how well chemotherapy will work afterward. Depending on the extent of disease, this can involve removal of the ovaries, uterus, and sometimes portions of nearby organs or the lining of the abdomen.

Stage at Diagnosis	Typical Surgical Approach
Early stage, confined to one or both ovaries	Surgery to remove the ovaries and surrounding tissue, sometimes with fertility-preserving options
Locally advanced, spread within the pelvis or abdomen	Full debulking surgery to remove all visible disease where possible
Extensive disease at diagnosis	Chemotherapy first to shrink the tumor, followed by interval debulking surgery

Fertility Preservation for Younger Patients

For younger patients with early-stage disease confined to one ovary, it is sometimes possible to preserve the uterus and the unaffected ovary, keeping fertility intact while still treating the cancer appropriately. This is only suitable for a specific subset of cases and is discussed openly during staging, rather than assumed to be an option for everyone.

Chemotherapy and Ovarian Cancer Treatment

Chemotherapy is combined with surgery in most ovarian cancer cases, either after debulking surgery to eliminate remaining microscopic disease, or before surgery when the extent of disease makes an upfront operation less safe or effective.

When Chemotherapy Comes After Surgery

This is the more common sequence for early to moderately advanced disease, where debulking surgery is performed first and chemotherapy follows to reduce the chance of recurrence.

When Chemotherapy Comes Before Surgery

For more extensive disease at diagnosis, chemotherapy is sometimes given first (neoadjuvant) to shrink the tumor burden, making a subsequent, more complete debulking surgery safer and more effective.

Ovarian Cancer Treatment Cost for Dubai Patients

Cost depends on the extent of surgery required, whether chemotherapy is given before or after the operation, and how many cycles are needed. A written cost estimate covering surgery, hospital stay, and the chemotherapy plan is provided once staging is complete.

Ovarian Cancer Treatment for Patients in Riyadh, Jeddah and Kuwait

The same review process is available to patients researching ovarian cancer treatment from Riyadh, Jeddah, and Kuwait. Existing imaging, CA-125 results, and any genetic testing already done can be sent for review, followed by a video consultation to discuss the surgical and chemotherapy plan.

How to Get Your Case Reviewed

Send your imaging reports, CA-125 results, and any biopsy or genetic testing already completed through the online second opinion page. You will receive a clinical review followed by a video call to discuss staging, the surgical plan, and whether chemotherapy would come before or after surgery in your case.

Frequently Asked Questions

Find answers to common questions about ovarian cancer surgery, debulking, BRCA testing, fertility preservation, and international patient care.

Debulking, or cytoreductive, surgery aims to remove as much visible tumor as possible, since less disease left behind generally means chemotherapy works better afterward. The extent of surgery depends on how far the cancer has spread.

It is now considered a standard part of ovarian cancer workup, since a meaningful number of cases are linked to inherited BRCA mutations, which can affect treatment choices. Whether it changes your specific plan is discussed during your review.

The initial review and consultation happen by video call, so you understand your staging and treatment plan before deciding anything. If you choose to proceed, surgery takes place at Dr. Tiwari's hospital, with full travel and logistics details explained clearly in advance.

For a specific subset of younger patients with early-stage disease confined to one ovary, fertility-preserving surgery may be possible. This is assessed individually and is not an option for every stage or type of ovarian cancer.

No. For more extensive disease at diagnosis, chemotherapy is sometimes given first (neoadjuvant) to shrink the tumor before a more complete debulking surgery. The sequence depends on your specific staging.

Yes, the same review and consultation process is available to patients from Riyadh, Jeddah, and Kuwait, not only Dubai.